Abstract:ABSTRACT Loss of proteostasis and cellular senescence are key hallmarks of aging. Recent studies suggest that lung fibroblasts from idiopathic pulmonary fibrosis (IPF) show features of cellular senescence, decline in heat shock proteins (HSPs) expression and impaired protein homeostasis (proteostasis). However, direct cause-effect relationships are still mostly unknown. In this study, we sought to investigate whether the heat shock factor 1 (HSF1), a major transcription factor that regulates the cellular HSPs network and cytoplasmic proteostasis, contributes to cellular senescence in lung fibroblasts. We found that IPF lung fibroblasts showed an upregulation in the expression of various cellular senescence markers, including β-galactosidase activity (SA-β-gal) staining, the DNA damage marker γH2Ax, the cell cycle inhibitor protein p21, and multiple senescence-associated secretory proteins (SASP), as well as upregulation of collagen 1a1, fibronectin and alpha-smooth muscle actin (α-SMA) gene expression compared with age-matched controls. These changes were associated with impaired proteostasis, as judged by an increase in levels of p-HSF1 ser307 and HSF1 K298 sumo , downregulation of HSPs expression, and increased cellular protein aggregation. Similarly, lung fibroblasts isolated from a mouse model of bleomycin-induced lung fibrosis and mouse lung fibroblast chronically treated with H 2 O 2 showed downregulation in HSPs and increased in cellular senescence and SASP markers. Moreover, sustained pharmacologic activation of HSF1 increased the expression of HSPs, reduced cellular senescence markers and effectively reduced the expression of pro-fibrotic genes in IPF fibroblast. Our data provide evidence that the HSF1-mediated proteostasis is important for driving lung fibroblasts toward cellular senescence and a myofibroblast phenotype. We postulate that enhancing HSF1 activity could be effective in the treatment of lung fibrosis.

Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis.

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

Plasminogen Activator Inhibitor 1, Fibroblast Apoptosis Resistance, and Aging-Related Susceptibility to Lung Fibrosis

Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B

Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation

Nitazoxanide alleviates experimental pulmonary fibrosis by inhibiting the development of cellular senescence

Aging of alveolar type 2 cells induced by Lonp1 deficiency exacerbates pulmonary fibrosis

Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation

Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells

Post-translational regulation of PGC-1α modulates fibrotic repair.

PTEN Loss Regulates Alveolar Epithelial Cell Senescence in Pulmonary Fibrosis Depending on Akt Activation.

Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis

[Progress on Correlation Between Cell Senescence and Idiopathic Pulmonary Fibrosis].

Impaired HSF1 transactivation drives proteostasis collapse and senescent phenotype of IPF lung fibroblast

YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis

Efficacy of YAP1-gene Knockdown to Inhibit Alveolar-Epithelial-Cell Senescence and Alleviate Idiopathic Pulmonary Fibrosis (IPF).

Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension

Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis

Loss of PTPN21 disrupted mitochondrial metabolic homeostasis and aggravated experimental pulmonary fibrosis

Cellular Senescence in Lung Fibrosis